Longitudinal cardiac imaging for assessment of myocardial injury in non-hospitalised community-dwelling individuals after COVID-19 infection: the Rotterdam Study

Publication date

2025-10-29

Authors

Van Den Heuvel, Frederik
Aribas, Elif
Tilly, Martijn J.
Geurts, Sven
Yang, Shuyue
Lu, Zuolin
De Groot, Natasja M.S.
Van Den Bosch, Annemien E.
Eijsvogels, Thijs M.H.
Peeters, Robin

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by_nc

Abstract

Background: The aim of this study was to assess the presence of myocardial injury after COVID-19 infection and to evaluate the relation between persistent cardiac symptoms after COVID-19 and myocardial function in participants with known cardiovascular health status before infection. Methods: In the prospective population-based Rotterdam Study cohort, echocardiography and cardiovascular magnetic resonance (CMR) were performed among participants who recovered from COVID-19 at home within 2 years prior to inclusion in the current study. Persistent cardiac symptoms comprised only self-reported symptoms of chest pain, dyspnoea or palpitations lasting >4 weeks after COVID-19 infection. We used linear regression and linear mixed models to estimate and test age-adjusted and sex-adjusted mean differences (95% CIs) of (1) post-COVID-19 CMR-derived and echocardiographic-derived parameters among participants with and without persistent post-COVID-19 symptoms and (2) pre-COVID-19 and post-COVID-19 echocardiographic assessments. Results: 92 participants were included, with a mean age of 59±8 years of whom 52% were male. Normal post-COVID-19 CMR-derived left ventricular (LV) function and right ventricular ejection fraction were observed in 92% and 98% of participants, respectively. We observed normal native T1 relaxation times in 100%, normal extracellular volume in 98% and normal T2 relaxation times in 98% of the participants. Comparison of pre-COVID-19 and post-COVID-19 echocardiography revealed a significant but small decline in left ventricular ejection fraction (adjusted mean change -1.37% (95% CI -2.57%, -0.17%)) and global longitudinal strain (1.32% (95% CI 0.50%, 2.15%)). Comparing participants with and without persistent symptoms, there were no significant differences in adjusted CMR-derived ventricular volumes, LV function or presence of myocardial injury. Conclusions: Almost all recovered non-hospitalised COVID-19 participants had normal CMR-derived ventricular volumes and function, without relevant myocardial injury.

Keywords

COVID-19, Echocardiography, Magnetic Resonance Imaging, Cardiology and Cardiovascular Medicine, Journal Article

Citation

Van Den Heuvel, F, Aribas, E, Tilly, M J, Geurts, S, Yang, S, Lu, Z, De Groot, N M S, Van Den Bosch, A E, Eijsvogels, T M H, Peeters, R, Rutten, F, Geersing, G J, Van Rosmalen, J, Ikram, M A, Nijveldt, R, Hirsch, A & Kavousi, M 2025, 'Longitudinal cardiac imaging for assessment of myocardial injury in non-hospitalised community-dwelling individuals after COVID-19 infection : the Rotterdam Study', Heart, vol. 111, no. 22, pp. 1075-1083. https://doi.org/10.1136/heartjnl-2024-324316